3Kimmel D B.Mechanism of action,pharmacokinetic and phaxmacodynamic profile,and clinical applications of nitrogen-con-taining bisphosphonates[J].J Dent Res,2007,86 (11):1022-1033. 被引量：1
4Frith J C,Monkkonen J,Auriola S,et al.The molecular mechanism of action of the antiresorptive and anfiinflammatory drug clodronate:evidence for the formation in vivo of a metabolite that inhibits bone resorption and causes osteoclast and macrophage apoptosis[J].Arthritis Rheum,2001,44 (9):2201-2210. 被引量：1
5Coukell A J,Markham A.Pamidronate.A review of its use in the management of osteolytic bone metastases,tumour-induced hyperoalcacmia and Paget's disease of bone[J].Drugs Aging,1998,12(2):149-168. 被引量：1
6Luckman S P,Hnghes D E,Coxon F P,et al.Nitrogen-cantai-ning biophospbonates inhibit the mevalonate pathway and prevent post-tranalational prenylation of GTP-bioding proteins,including Ras[J].J Bone Miner Res,2005,20(7):1265-1274. 被引量：1
7Rogers M J,Gordon S,Benford H L,et al.Cellular and molecular mechanisms of action of bisphospbonates[J].Cancer,2000,88(12 Suppl):2961-2978. 被引量：1
8Frith J C,Rogers M J.Antagonistic effects of different classes of bisphosphonates in osteoclasts and macrophagess in vitro[J].J Bone Miner Res,2003,18(2):204-212. 被引量：1
9Giuliani N,Pedrazzoni M,Passeri G,et al.Bisphospbonatas in-hibit IL-6 production by human osteoblast-like cells[J].Scand J Rheumatol,1998,27(1):38-41. 被引量：1
10Viereck V,Emons G,Lauck V,et al.Bisphosphonates pamidronate and zoledronic acid stimulate osteoprotegerin production by primary human osteoblasts[J].Biochem Biophys Res Commun,2002,291 (3):680-686. 被引量：1
二级参考文献25
1[1]Fleisch H, Russell RGG, Francis MD. Diphosphonates inhibit hydroxy apatite dissolution in vitro and bone resorption in tissue culture and in vivo[J]. Science,1969, 165(899):1262～1264 被引量：1
2[2]Ebetino FH. Mechanisms of action of Etidronate and other bisphosphonates[J]. Rev Gontemp Pharma, 1998, 9:233～243 被引量：1
3[3]Fleisch H. Bisphosphonates: Mechanisms of action[J]. Endocr Rev, 1998,19(12):80～100 被引量：1
4[4]Boisser S, Magnetto S, Frappart LI, et al. Bisphosphonates inhibit breast and prostate cancer cell adhesion to unmineralized and mineralized bone matrices[J]. Cancer Res, 1997, 57(18):3890 ～3894 被引量：1
5[5]Menssen HD, Sakalova A, Herrman Z, et al. Effects of longterm intravenous Ibandronate therapy on skeletal -related events,survival,and bone resorption makers in patients with advanced multiple myeloma[J]. J Clin Oncol, 2002,20(9):2353～2359 被引量：1
6[6]Blomen LJMJ. History of bisphosphonates: Discovery and history of the non medical uses of bisphosphonates[M]. Amsterdam:Elsevier, 1995.111 ～ 124 被引量：1
7[7]Russell RG, Rongers MJ. Bisphosphonates: from the laboratory to clinic and back again[J]. Bone, 1999, 25(1):97～106 被引量：1
8[8]Fleisch H. Bisphosphonates in bone disease [M]. Academin Press(San Diego), 2000.31～32 被引量：1
9[9]Fleisch H. The bisphosphonates Ibandronate, given daily as well as discontinuously, decreases bone resorption and increases calcium retention as assessed by 45Ca kinetics in the intact rat[J]. Osteoporosis Int, 1996,6:166～170 被引量：1
10[10]Ravn P, Christense JO, Baumann M, et al. Changes in biochemical markers and bone mass after withdrawal of Ibandronate treatment: Prediction of bone mass changes during treatment[J]. Bone, 1998, 22(5):559～564 被引量：1
3Owman-Moll P, Kurol J. Root resorption after orthodon- tic treatment in high- and low-risk patients:analysis of al- lergy as a possible predisposing factor[J]. Eur J Orthod, 2000, 22(6) :657-663. 被引量：1
4Preoteasa C T, Ionescu E, Preoteasa E, et al. Orthodonti- cally induced root resorption correlated with morphological characteristics[J]. Rom J Morphol Embryol, 2009, 50 (2) :257-262. 被引量：1
5Okamura T, Shimokawa H, Takagi Y, et al. Detection of collagenase mRNA in odontoclasts of bovine root-resor- bing tissue by in situ hybridization[J]. Calcif Tissue Int,1993, 52(4) :325-330. 被引量：1
6Matsumoto Y. Morphological and functional properties of odontoclasts on dentine resorption [ J ]. Kokubyo Gakkai Zasshi, 1994, 61 ( 1 ) :123-143. 被引量：1
7Pecker R R, Saville P D. Intestinal absorption of disodi- um ethane-l-hydroxy-1, 1-diphosphonate ( disodium etidronate) using a deconvolution technique[J]. Toxicol Appl Pharrnacol, 1973, 24(4) :580-589. 被引量：1
8Warita H, Kirino Y, Kurihara S, et al. Effects of local injection with bisphosphonate (HEBP) on experimental tooth movement[J]. J Jpn Orthod Soc, 1992, 51:292- 301. 被引量：1
9Adachi H, Igarashi K, Mitani H, et al. Effects of topi- cal administration of a bisphosphonate (risedronate) on orthodontic tooth movement in rats[J]. J Dent Res, 1994, 73 ( 8 ) : 1478-1486. 被引量：1
10Keles A, Grunes B, Difuria C, et al. Inhibition of tooth movement by osteoprotegerin vs. pamidronate under con- ditions of constant orthodontic force[J]. Eur J Oral Sci, 2007, 115(2) :131-136. 被引量：1
